NAD+ and aging research shows a consistent pattern: NAD+ levels decline significantly with age, and preclinical studies in multiple models suggest that restoring them may support cellular energy, DNA repair, and longevity pathways. TelosRX offers asynchronous provider evaluations for NAD+-related protocols, subject to medical approval by a licensed provider.
NAD+ (nicotinamide adenine dinucleotide) is not a supplement trend. It's a coenzyme found in every living cell, and the science behind what happens to it as you age is some of the most studied — and most contested — in longevity medicine. Here's what the published research actually shows.
What Is NAD+ and Why Does It Matter?
NAD+ is a coenzyme that shuttles electrons in cellular metabolism. Every cell in your body uses it. Without it, mitochondria can't produce ATP (the cell's energy currency), DNA repair enzymes can't function, and sirtuins — a family of proteins linked to longevity regulation — can't operate.
NAD+ exists in two forms: NAD+ (oxidized) and NADH (reduced). The ratio between them reflects cellular metabolic state. In aging tissue, total NAD+ declines — reducing the pool available for all of these processes.
Finding 1: NAD+ Declines Substantially with Age
A foundational finding in the NAD+ aging literature is that tissue levels drop significantly across the human lifespan. Studies have measured NAD+ in human blood, skin, and muscle tissue across age groups.
| Study / Source | Key Finding | Notes |
|---|---|---|
| Yoshino et al., Cell Metabolism, 2011 | NAD+ declines in aged mice and humans; NMN supplementation restored levels in mice | Preclinical + early human data |
| Massudi et al., PLOS ONE, 2012 | NAD+ levels in human skin decline ~1% per year from age 20 onward | Human tissue biopsy study |
| Elhassan et al., Cell Reports, 2019 | Skeletal muscle NAD+ declines with age; precursors raised blood NAD+ levels in older adults | Human RCT |
The consistent thread: NAD+ goes down. What researchers are still working out is whether supplementation reverses the downstream consequences — or just raises a number.
Finding 2: NAD+ and Sirtuin Activation
Sirtuins (SIRT1–SIRT7) are NAD+-dependent enzymes involved in gene expression, inflammation regulation, and DNA repair. They can only function when NAD+ is available — they literally consume it as they work.
Research from David Sinclair's lab at Harvard has positioned sirtuins — especially SIRT1 and SIRT3 — as key nodes in the biology of aging. Preclinical studies show that raising NAD+ levels (via NMN or NR precursors) can activate sirtuin pathways in aged mice, improving markers of metabolic health and physical function.
Human translation is more complex. A 2020 study published in Cell Reports showed that NR supplementation raised whole-blood NAD+ in older adults and activated SIRT1 in peripheral blood mononuclear cells — but functional outcomes were more variable.
Finding 3: NAD+ and Mitochondrial Function
Mitochondria — the organelles that generate ATP — depend on NAD+ to run the electron transport chain. As NAD+ falls with age, mitochondrial efficiency declines. This is associated with reduced energy production, increased oxidative stress, and the accumulation of dysfunctional mitochondria that characterizes aged tissue.
A 2013 study in Cell (Gomes et al.) demonstrated that raising NAD+ in aged mice restored mitochondrial homeostasis and reduced markers of muscle atrophy within a week. This is preclinical evidence — but it's mechanistically compelling.
In a human trial, Martens et al. (2018) found that NMN supplementation improved muscle function in older men, suggesting at least some mitochondrial benefit in aging humans. The study was small; larger trials are ongoing.
Finding 4: NAD+ and DNA Repair
PARP enzymes (poly ADP-ribose polymerases) are the primary repair machinery for DNA strand breaks. They consume NAD+ — rapidly and in large amounts — when DNA damage is detected. In aging tissue, where both DNA damage accumulates and NAD+ is depleted, PARPs may be competing with sirtuins for a diminishing resource.
Research suggests that maintaining higher NAD+ levels may support more effective DNA repair responses. This is studied primarily in preclinical models; direct human evidence is limited but consistent with the mechanistic hypothesis.
Finding 5: Human Clinical Evidence — What's Been Measured
The clinical evidence for NAD+ supplementation in aging humans is growing but still early. Here's a summary of what controlled trials have measured:
| Outcome Measured | Result | Confidence Level |
|---|---|---|
| Blood NAD+ levels after supplementation | Reliably increased by NMN and NR | Well-established (multiple RCTs) |
| Muscle function / physical performance | Modest improvement in older adults (Martens 2018) | Promising; small trials |
| Insulin sensitivity | Improved in prediabetic women (Yoshino 2021) | Promising; needs replication |
| Cognitive function | Exploratory data; no large RCTs yet | Insufficient evidence |
| Cardiovascular function | Early signals; ongoing trials | Insufficient evidence |
| Subjective energy and sleep | Self-reported improvement common; hard to measure objectively | Low (high placebo sensitivity) |
The honest read: NAD+ supplementation reliably raises NAD+ levels in blood. Whether that translates to meaningful clinical outcomes in aging humans — at what dose, for whom, for how long — is still being established.
NAD+ Delivery Methods: What the Research Uses
NAD+ itself is not efficiently absorbed orally (it degrades in the gut). Clinical research typically uses precursors or direct IV/injection routes:
- NMN (nicotinamide mononucleotide): Oral precursor; well-studied; absorbed and converted to NAD+ in tissue
- NR (nicotinamide riboside): Oral precursor; multiple RCTs; similar mechanism to NMN
- IV NAD+: Direct infusion; rapid blood level increase; used clinically; requires provider oversight
- Subcutaneous / intramuscular NAD+: Studied in clinical settings; subject to medical approval by a licensed provider
For an in-depth comparison of NMN vs. NR specifically, see the NMN vs. NR comparison.
Interested in provider-reviewed NAD+ protocols? Explore longevity protocols at TelosRX — evaluated asynchronously by a licensed provider.
What the Research Does Not Show
To be clear about what the evidence doesn't support:
- NAD+ supplementation does not demonstrably extend human lifespan in any completed trial
- The “reversing aging” framing seen in consumer marketing overstates current evidence
- Individual response varies substantially — blood NAD+ going up doesn't guarantee any specific clinical outcome
The science is genuinely interesting. The certainty in popular coverage is not warranted by the published data.
Frequently Asked Questions
Does NAD+ really decline with age?
Yes — this is one of the more consistent findings in aging biology. Multiple studies using human tissue biopsies and blood measurements show declining NAD+ levels from early adulthood onward. The rate varies by tissue type and individual. The downstream effects of this decline are still being characterized.
Can NAD+ supplementation slow aging?
Preclinical research in animal models is compelling — raising NAD+ in aged mice improved multiple markers of aging. Human evidence is more limited and specific: supplementation reliably raises blood NAD+ levels, and some trials report improvements in muscle function and insulin sensitivity. Whether this translates to meaningful “slowing” of human aging is not established by current RCTs.
What is the best way to raise NAD+ levels?
Oral precursors NMN and NR are the most studied approaches and have been shown to raise blood NAD+ in multiple human trials. IV and injectable NAD+ raise levels more rapidly but require clinical administration. Exercise and caloric restriction also support NAD+ metabolism. A provider can help determine the most appropriate approach for your situation.
How long does it take to see results from NAD+ supplementation?
Blood NAD+ levels typically rise within days to weeks of supplementation. Functional outcomes — if they appear — are studied over 8–12 weeks or longer in clinical trials. Subjective energy or sleep changes are often reported earlier, though these are harder to measure objectively. Individual variation is significant.
Is NAD+ supplementation safe?
Oral NMN and NR have generally favorable safety profiles in completed human trials at doses studied. IV NAD+ requires provider oversight. As with any protocol, a licensed provider should review your health history before initiating supplementation. Subject to medical approval by a licensed provider.
What is the role of sirtuins in NAD+ and aging?
Sirtuins are NAD+-dependent enzymes involved in DNA repair, inflammation regulation, and gene expression. They require NAD+ to function and consume it as they work. Preclinical research links sirtuin activation to longevity-related pathways, and some human trials show that raising NAD+ activates SIRT1 in blood cells — though the downstream effects in humans remain under active investigation.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.